Skip to main content
Log in

DPP-4 inhibitors not cost effective in elderly in Thailand

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Permsuwan U, et al. Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand. ClinicoEconomics and Outcomes Research : 21 Sep 2016. Available from: URL: https://dx.doi.org/10.2147/CEOR.S113559

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

DPP-4 inhibitors not cost effective in elderly in Thailand. PharmacoEcon Outcomes News 763, 14 (2016). https://doi.org/10.1007/s40274-016-3427-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3427-0

Navigation